在多发性硬化症中量化干扰素和格拉西莫特停止使用后疾病再激活的风险：VIAADISC评分

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Recurrence or rebound of clinical relapses after discontinuation of natalizumab therapy in highly active MS patients2014 · 141 citations
2. 2Current therapeutic landscape in multiple sclerosis: an evolving treatment paradigm2019 · 94 citations
3. 3Measures in the first year of therapy predict the response to interferon β in MS2009 · 242 citations
4. 4Significant clinical worsening after natalizumab withdrawal: Predictive factors2014 · 53 citations
5. 5Discontinuation of disease-modifying treatments for multiple sclerosis in patients aged over 50 with disease Inactivity2020 · 36 citations